BeStock  

Opko Health OPK

US equityMarket cap rank #3057Diagnostics & Research
$1.57 −$0.04 (-2.48%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.57 +0.04%
Open$1.57
Prev close$1.61
Day range$1.55 – $1.62
Volume3.52M
Market cap$1.17B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$65.41M+15.9% YoY
Operating profit-$31.41M+6.4% YoY
Net profit-$53.53M-347.5% YoY
Diluted EPS-$0.07-333.3% YoY
Free cash flow-$39.61M-4.8% YoY
Operating cash flow-$36.32M

Revenue, last 8 quarters

$183.6MDec '24$150.0MMar '25$156.8MJun '25$56.4MSep '25$447.6MDec '25$124.2MMar '26$163.6MJun '26$65.4MSep '26

Net profit, last 8 quarters

$14.0MDec '24$-67.6MMar '25$-148.4MJun '25$21.6MSep '25$-31.3MDec '25$-54.8MMar '26$-8.4MJun '26$-53.5MSep '26

Diluted EPS by quarter

0.01Dec '24-0.10Mar '25-0.19Jun '250.03Sep '25-0.04Dec '25-0.07Mar '26-0.01Jun '26-0.07Sep '26

Free cash flow by quarter

$-49.8MDec '24$-37.7MMar '25$-86.7MJun '25$-37.8MSep '25$-28.6MDec '25$-21.1MMar '26$-46.5MJun '26$-39.6MSep '26

Annual revenue

$1.4BFY20$1.8BFY21$1.0BFY22$863.5MFY23$713.1MFY24$606.9MFY25

Profitability & balance sheet

Gross margin38.5%
Operating margin-27.7%
Net margin-22.6%
Return on equity-12.2%
Return on assets-7.6%
Return on invested capital-6.9%
Current ratio4.97
Liabilities / assets40.6%
Cash & investments$390.22M
Total debt$506.88M
Net cash (debt)-$116.66M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Global Products$48.45M 74.1%
  • Innovative biotech$16.97M 25.9%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $65.41M $163.58M $124.20M $606.88M $447.64M
Total Operating Revenue $65.41M $163.58M $124.20M $606.88M $447.64M
Cost of Revenue $23.35M $83.56M $78.44M $400.94M $331.73M
Gross Profit $42.06M $80.02M $45.76M $205.94M $115.91M
Operating Expense $73.47M $105.06M $96.77M $424.93M $215.98M
Selling and Admin Expenses $24.84M $52.92M $48.61M $223.00M $153.47M
Research & Development $32.18M $33.17M $29.20M $124.03M $33.69M
Depreciation & Amortization & Depletion $16.46M $18.97M $18.97M $77.89M $28.83M
-Depreciation & Amortization $16.46M $18.97M $18.97M $77.89M $28.83M
Operating Profit -$31.41M -$25.04M -$51.02M -$218.99M -$100.07M
Net Non-Operating Interest Income (Expense) -$10.57M -$8.16M -$7.93M -$93.65M -$6.73M
Non-Operating Interest Income $2.88M $3.22M $3.01M $14.81M $4.70M
Non-Operating Interest Expense $13.45M $11.38M $10.94M $108.46M $11.43M
Other Income (Expense) $4.11M $19.80M -$2.01M $71.27M $103.50M
Gain on Sale of Security $251,000.00 -$65,000.00 -$298,000.00 -$429,000.00 -$134,000.00
Other Non-Operating Income (Expenses) $3.86M $1.80M -$1.71M -$29.88M $2.06M
Pretax Profit -$37.87M -$13.40M -$60.96M -$241.36M -$3.30M
Tax -$7.31M -$4.98M -$6.11M -$15.71M $13.30M
$5.00M $0.00 $2,000.00 $29,000.00 $17,000.00
Net Profit -$53.53M -$8.42M -$54.85M -$225.68M -$31.26M
Profit from Continuing Operations -$35.56M -$8.42M -$54.85M -$225.68M -$16.62M
Net Income from Discontinuous Operations -$17.98M – – – –
Net Income to Parent Company -$53.53M -$8.42M -$54.85M -$225.68M -$31.26M
Net Income to Common Stockholders -$53.53M -$8.42M -$54.85M -$225.68M -$31.26M
Basic EPS -$0.07 -$0.01 -$0.07 -$0.30 -$0.04
Diluted EPS -$0.07 -$0.01 -$0.07 -$0.30 -$0.04
Special Income (Charges) – $18.07M – $101.58M $0.00
-Gain on Sale of Property/Plant/Equipment – $18.07M – $101.58M $0.00
-Less:Restructuring and Mergern & Acquisition – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.88B $1.83B $1.86B $1.93B $1.93B
Total Current Assets $806.28M $500.24M $535.36M $581.88M $581.88M
Cash and Cash Equivalents & Short-Term Investments $390.22M $300.76M $341.88M $369.07M $369.07M
-Cash and Cash Equivalents $390.22M $300.76M $341.88M $369.07M $369.07M
Receivables $94.92M $114.91M $107.62M $126.12M $126.12M
-Accounts Receivable $80.21M $81.89M $79.64M $90.26M $90.26M
-Taxes Receivable $7.59M $7.84M $6.06M $11.84M $11.84M
-Other Receivables $7.11M $25.19M $21.93M $24.02M $24.02M
Prepaid Assets $12.43M $12.87M $11.71M $12.70M $12.70M
Inventory $50.60M $61.85M $64.40M $65.82M $65.82M
Other Current Assets $10.05M $9.84M $9.76M $8.17M $8.17M
Total Non-Current Assets $1.07B $1.33B $1.32B $1.35B $1.35B
Net PPE $101.91M $115.43M $118.39M $120.86M $120.86M
-Gross PPE $101.91M $115.43M $118.39M $246.47M $246.47M
Investments and Advances $44.50M $40.21M $10.53M $14.17M $14.17M
-Available for Sale Securities $43.74M $39.46M $9.77M $13.41M $13.41M
-Long Term Equity Investment $755,000.00 $755,000.00 $756,000.00 $758,000.00 $758,000.00
Financial Assets $0.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
Goodwill and Other Intangible Assets $908.53M $1.15B $1.17B $1.20B $1.20B
-Goodwill $317.36M $481.52M $482.27M $484.29M $484.29M
-Other Intangible Assets $591.17M $672.57M $691.35M $711.28M $711.28M
Other Non-Current Assets $19.04M $19.49M $18.90M $19.47M $19.47M
Total Liabilities $764.08M $645.29M $652.19M $663.99M $663.99M
Total Current Liabilities $162.36M $149.37M $148.38M $146.68M $146.68M
Payables $56.89M $56.47M $48.81M $44.70M $44.70M
-Accounts Payable $47.92M $50.04M $44.18M $41.10M $41.10M
-Total Tax Payable $8.97M $6.43M $4.63M $3.60M $3.60M
Current Accrued Expenses $38.22M $35.55M $36.30M $39.45M $39.45M
Short-Term Debt and Capital Lease Obligation $21.92M $22.96M $22.26M $22.86M $22.86M
-Current Debt $13.15M $10.56M $9.65M $10.25M $10.25M
-Current Capital Lease Obligation $8.77M $12.40M $12.61M $12.61M $12.61M
Current Provisions $5.71M $5.43M $5.79M $5.90M $5.90M
Other Current Liabilities $9.42M – – – –
Total Non-Current Liabilities $601.72M $495.92M $503.80M $517.31M $517.31M
Long Term Debt and Capital Lease Obligation $493.73M $375.13M $374.67M $373.92M $373.92M
-Long Term Debt $464.25M $338.49M $336.03M $333.72M $333.72M
-Long Term Capital Lease Obligation $29.49M $36.64M $38.64M $40.21M $40.21M
Non-Current Deferred Liabilities $96.67M $108.23M $114.56M $126.24M $126.24M
Employee Benefits $0.00 $1.18M $3.19M $5.54M $5.54M
Other Non-Current Liabilities $11.32M $11.39M $11.38M $11.60M $11.60M
Total Equity $1.12B $1.18B $1.20B $1.27B $1.27B
Stockholders' Equity $1.12B $1.18B $1.20B $1.27B $1.27B
Capital Stock $7.43M $7.76M $7.85M $7.90M $7.90M
-Common Stock $7.43M $7.76M $7.85M $7.90M $7.90M
Additional Paid-In Capital $3.55B $3.56B $3.57B $3.57B $3.57B
Retained Earnings -$2.41B -$2.35B -$2.35B -$2.29B -$2.29B
Less: Treasury Stock $0.00 -$2.36M -$1.79M -$3.18M -$3.18M
Gains/Losses Not Affecting Retained Earnings -$33.30M -$28.39M -$27.49M -$21.02M -$21.02M
-Accumulated Depreciation – – – -$125.62M -$125.62M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$36.32M -$43.50M -$19.31M -$178.54M -$25.92M
Net cash flow from continuing operations -$36.32M -$43.50M -$19.31M -$178.54M -$25.92M
Net Income from Continuing Operations -$53.53M -$8.42M -$54.85M -$225.68M -$31.26M
Gain/Loss from Continuing Operations $5.05M -$45.19M -$32,000.00 -$72.15M $33.27M
Depreciation & Depletion & Amortization $22.73M $22.41M $22.20M $91.63M $22.37M
Deferred Tax -$10.05M -$6.27M -$7.89M -$15.00M -$10.15M
Other Non-Cash Items $2.85M $2.69M $2.57M $71.49M -$30.12M
Change in Working Capital -$1.02M -$8.61M $12.02M -$41.18M -$12.13M
-Change in Receivables $198,000.00 -$2.39M $9.53M $30.21M $6.71M
-Change in Inventory -$1.95M $2.84M $191,000.00 -$4.12M $1.17M
-Change in Payables and Accrued Expense $3.59M -$2.94M -$4.67M -$62.06M -$20.84M
-Change in Other Current Assets -$2.82M -$6.26M $6.84M -$5.40M -$4.02M
-Change In Other Working Capital -$30,000.00 $136,000.00 $126,000.00 $178,000.00 $4.84M
Net cash flow from investing $11.30M $15.54M -$1.80M $230.30M -$2.05M
Net Cash Flow from Continuing Investing Activities $11.30M $15.54M -$1.80M $230.30M -$2.05M
Capital Expenditure -$2.79M -$3.00M -$1.83M -$12.28M -$2.67M
Net PPE Purchase and Sale $49,000.00 $148,000.00 $33,000.00 $287,000.00 $93,000.00
Net Business Purchase and Sale $14.54M $18.39M $0.00 $190.11M $0.00
Net Investment Purchase and Sale $0.00 $0.00 $0.00 $52.18M $527,000.00
Financing Cash Flow $114.47M -$13.03M -$5.16M -$118.06M -$18.34M
Net Cash Flow from Continuing Financing Activities $114.47M -$13.03M -$5.16M -$118.06M -$18.34M
Net Issuance Payments Of Debt $126.02M $333,000.00 -$390,000.00 -$70.76M -$4.70M
Net Common Stock Issuance -$10.63M -$13.02M -$4.77M -$47.04M -$13.51M
Proceeds from Stock Option Exercised -$922,000.00 -$339,000.00 $0.00 -$256,000.00 -$133,000.00
Ending Cash Balance $403.22M $314.43M $355.57M $382.74M $382.74M
Net Change in Cash $89.45M -$40.99M -$26.27M -$66.30M -$46.31M
Beginning Cash Balance $314.43M $355.57M $382.74M $445.62M $428.87M
Effect of Exchange Rate Changes -$663,000.00 -$145,000.00 -$908,000.00 $3.43M $174,000.00
Free Cash Flow -$39.61M -$46.50M -$21.14M -$190.82M -$28.59M

Discussion

No comments yet — be the first to weigh in on OPK.

Sign in to join the discussion.

Scroll to Top